• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185
• 4. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyrimidines Purinones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyrimidines Purines and purine derivatives Purinones
• Solvents and Organic Chemicals Organic Compounds Heterocyclic Compounds
• Solvents and Organic Chemicals Organic Compounds Acids/Esters
• Other Chemical Reagents

N2-Acetylguanine: A Key Compound in Biomedical Research and Its Multifaceted Applications

N2-Acetylguanine, with the chemical identifier CAS No. 19962-37-9, represents a unique molecular structure that has garnered significant attention in the field of biomedical sciences. This compound is a derivative of guanine, one of the fundamental nucleobases in DNA and RNA, and its acetylated form has been the focus of extensive research due to its potential roles in cellular processes and therapeutic applications. Recent studies have highlighted the N2-Acetylguanine’s involvement in DNA repair mechanisms, its interactions with enzymatic pathways, and its potential as a candidate for drug development targeting specific diseases. The compound’s structural characteristics and functional properties make it a promising subject for both academic exploration and industrial innovation.

The N2-Acetylguanine molecule is characterized by its acetylation at the N2 position of the purine ring, which modifies its chemical reactivity and biological activity compared to native guanine. This structural modification is critical for its role in various biological contexts, such as nucleotide metabolism and epigenetic regulation. Researchers have recently reported that the N2-Acetylguanine derivative exhibits enhanced stability under physiological conditions, which could be a key factor in its potential therapeutic applications. A 2023 study published in Journal of Medicinal Chemistry demonstrated that the N2-Acetylguanine compound shows significant selectivity toward specific DNA repair enzymes, suggesting its potential as a tool for modulating cellular repair processes.

One of the most intriguing aspects of N2-Acetylguanine is its role in the context of DNA damage response. DNA repair mechanisms are essential for maintaining genomic integrity, and disruptions in these processes are linked to various diseases, including cancer. Recent advancements in molecular biology have revealed that N2-Acetylguanine may act as a modulator of base excision repair (BER) pathways. A 2024 study in Cell Reports showed that the compound interacts with PARP1, a key enzyme in BER, to enhance the efficiency of DNA strand repair. This finding has sparked interest in exploring N2-Acetylguanine as a potential therapeutic agent for conditions associated with DNA damage, such as neurodegenerative disorders and certain types of cancer.

Another area of focus is the N2-Acetylguanine’s potential as an antiviral agent. Viral infections often rely on host cell machinery for replication, and compounds that can interfere with these processes are highly sought after. A 2023 study in Antiviral Research investigated the antiviral activity of N2-Acetylguanine against herpes simplex virus (HSV). The results indicated that the compound inhibits viral DNA replication by interfering with the activity of thymidine kinase, a critical enzyme in viral replication. This discovery highlights the N2-Acetylguanine’s potential as a novel antiviral compound, particularly for treating HSV infections that are resistant to current therapies.

In addition to its roles in DNA repair and antiviral activity, N2-Acetylguanine has also been explored for its potential in cancer therapy. Cancer cells often exhibit defects in DNA repair mechanisms, making them more susceptible to compounds that target these pathways. A 2024 study published in Cancer Research demonstrated that N2-Acetylguanine selectively induces apoptosis in cancer cells while sparing normal cells. This selectivity is attributed to the compound’s ability to disrupt the balance of reactive oxygen species (ROS) in tumor cells, leading to oxidative stress and cell death. These findings suggest that N2-Acetylguanine could be a valuable candidate for developing targeted cancer therapies.

The synthesis of N2-Acetylguanine has also been a subject of recent research, with scientists aiming to optimize its production for large-scale applications. Traditional methods for synthesizing nucleobase derivatives often involve complex chemical reactions and harsh conditions, but recent advancements in green chemistry have led to more sustainable approaches. A 2023 study in Organic Letters reported a novel, environmentally friendly method for synthesizing N2-Acetylguanine using microwave-assisted reactions. This method not only improves the yield of the compound but also reduces the use of hazardous solvents, aligning with the growing emphasis on sustainable practices in pharmaceutical research.

Furthermore, the N2-Acetylguanine’s potential in epigenetic regulation has attracted attention. Epigenetic modifications, such as DNA methylation and histone acetylation, play critical roles in gene expression and cellular differentiation. Researchers have hypothesized that N2-Acetylguanine may influence these processes by interacting with histone deacetylases (HDACs) or DNA methyltransferases (DNMTs). A 2024 study in Nucleic Acids Research found that the compound modulates the activity of HDAC6, a protein involved in neurodegenerative diseases. This discovery opens new avenues for exploring N2-Acetylguanine as a potential therapeutic agent for conditions such as Alzheimer’s disease and Parkinson’s disease.

Despite the promising findings, challenges remain in translating N2-Acetylguanine’s potential into clinical applications. One of the primary obstacles is ensuring the compound’s bioavailability and stability in vivo. While in vitro studies have demonstrated its efficacy, further research is needed to optimize its pharmacokinetic properties. Additionally, the long-term safety profile of N2-Acetylguanine must be thoroughly evaluated to rule out potential toxic effects. Ongoing clinical trials are expected to provide critical insights into these aspects, paving the way for its potential use in therapeutic settings.

In conclusion, N2-Acetylguanine represents a versatile compound with diverse applications in biomedical research. Its roles in DNA repair, antiviral activity, cancer therapy, and epigenetic regulation highlight its significance as a target for further investigation. As research continues to uncover new mechanisms and applications, the N2-Acetylguanine’s potential to contribute to the development of innovative therapies remains a focal point for scientists and pharmaceutical researchers alike.

• 23199-21-5(6H-Purin-6-one-8-t,2-amino-1,7-dihydro- (9CI))
• 10030-78-1(2-(Methylamino)-1H-purin-6(7H)-one)
• 11046-95-0(Hemoglobin Gun Hill(9CI))
• 60049-89-0(6H-Purin-6-one,2-amino-1,9-dihydro-, hydrobromide (1:1))
• 52994-57-7(6H-Purin-6-one, 2-amino-1,7-dihydro-, sodium salt)
• 33735-91-0(6H-Purin-6-one,2-amino-1,9-dihydro-, hydrochloride (1:?))
• 19545-00-7(2-(ethylamino)-9H-purin-6-ol)
• 635-39-2(Guanine hydrochloride)
• 23199-24-8(6H-Purin-6-one-8-14C,2-amino-1,7-dihydro- (9CI))
• 67018-58-0(6H-Purin-6-one, 2-amino-1,7-dihydro-, monosodium salt)